DNA Asset Management

We provide high-conviction, research-driven strategies to investors in the digital asset market.


Why Invest With DNA Asset Management?


The explosion in the crypto asset class has created many attractive investment opportunities, spanning hundreds of exchanges and tens of thousands of different tokens.

The DNA Asset Management team has nearly 30 years experience, investing across the entire capital stack of digital asset markets, while navigating two markets cycles together as a team.

The DNA Advantage:

The broader DNA Holdings business provides market insights, connections through events and preferable deal-flow which equates to quantifiable advantages as an allocator of capital.

Team Members


Photo of Thomas McLaughlin

Thomas McLaughlin

Chief Investment Officer

One of the industry’s foremost leaders in liquid crypto markets, with experience trading and investing in digital assets since 2016.

Photo of Chase Mayeux

Chase Mayeux

Chief Operating Officer

Operations professional with over fifteen years of experience, Chase Mayeux brings expertise from dynamic startups and leading Fortune 500 companies. Prior to joining DNA, he served as Investment Relations Officer at OnChain Alpha and Chief Operating Officer at Coral Capital. He holds a dual degree in Marketing and Management from Texas Tech University’s Rawls College of Business.

Photo of JR Pasch

JR Pasch

Head of Quantitative Research & Portfolio Manager

JR served as a 61A research analyst in the United States Air Force, and his 9+ years of military service have bolstered his education on modeling, machine learning, and simulation.

Photo of Josh Krugger

Josh Krugger

Head of Trading & Portfolio Manager

Directs multi-strategy liquid token portfolio integrating systematic regime models, discretionary thematic allocations, and market-neutral positioning.
- Partner & Head of Trading, Coral Capital (2022); $100M+ AUM across DeFi market neutral and venture strategies; acquired by DNA in 2024.
- Lead Architect, Tokenomics & Game Theory, Tea Protocol (2023); protocol incentive design alongside Max Howell, optimizing decentralized open-source contribution networks.

Photo of Justin Vlahos

Justin Vlahos

Portfolio Manager

Manages the multi-strategy liquid token portfolio that integrates systematic regime-based modeling with tactical positioning to optimize risk-adjusted returns. He brings over five years of experience in digital asset markets, with deep expertise in derivatives trading—specifically perpetual futures and options—used to calibrate portfolio beta and implement robust risk management frameworks.

DNA Asset Management Funds

DNA Offers a variety of investment vehicles tailored to investor risk appetites and exposure needs designed to advantage of opportunities within the crypto asset class.


DNA Liquid Token Fund

  • Thesis-driven exposure to a diversified portfolio of liquid tokens.
  • Leverage sentiment analysis and macroeconomic and industry-specific data point to handicap and allocate to the sectors and projects within crypto with the highest asymmetric upside.

DNA High-Yield

  • Market-neutral fund vehicle that capitalizes on the premium paid to borrow dollar-denominated tokens (Stablecoins) by lending tokens to traders who pay interest to borrow.
  • Generates yield in the form of US Dollars with a target to outperform US Treasuries by a significant margin on a risk-adjusted basis.

The Crypto Asset Class Has Shown Significant Growth

Despite significant volatility and an ever-changing global regulatory landscape toward the asset class, crypto continues to push higher; signaling a broader acceptance from both retail investors and institutional allocators.

2020

$0.9 Trillion

2021

$2.5 Trillion

2022

$0.8 Trillion

2023

$1.8 Trillion

2024

$3.9 Trillion

Source: Total 3 Markter Capitalization from Tradingview

Performance Since Inception of DNA AM

Return metrics for DNA Liquid funds vs popular benchmarks since February 2021.


Annualized ReturnMax Drawdown
90 Day T-Bills2.78%n/a
S&P US Bond Index(1.21%)(15.00%)
DNA High-Yield Fund12.37%(1.28%)
S&P50014.10%(27.54%)
FAANG14.25%(31.79%)
DNA Liquid Token Fund19.04%(15.83%)

Case Studies


Connect with us.

We are looking to connect with investors and projects who look to expand their ecosystem and scale their growth through our network of experienced professionals.